BASF partners with Acies Bio to drive sustainable production of Personal and Home Care ingredients
Partnership on biotechnology supports the further development of fermentation technology
BASF and Acies Bio, one of Europe’s leading biotechnology companies, have entered into a transformative partnership to further develop a platform for fermentation technology from Methanol for the production of fatty alcohols. Fatty alcohols are essential building blocks for several ingredients in the home and personal care markets, in particular surfactants. Acies Bio’s biotechnological expertise complements BASF’s drive for innovative solutions and contributes to shaping a more sustainable future.
Acies Bio has developed the “OneCarbonBio”, a fully flexible synthetic biology platform designed to efficiently convert renewable methanol, derived from captured CO2 emissions, into a variety of chemical raw materials. Under the terms of the partnership, BASF’s Care Chemicals division and Acies Bio will use the specialized microbes and scale up the fermentation process to produce fatty acids and derivatives serving to manufacture various chemical compounds. BASF will contribute its expertise in developing processes, providing integrated value chain solutions and accessing global markets.
Acies Bio and BASF aim to combine their strengths in a co-development effort and to build on their combined research and development expertise. For BASF, the expected benefits of the project include increased scale and flexibility, leading to a diversification of the renewable feedstock portfolio and contributing to the resilience of Care Chemicals’ global supply chain.
“Biotechnology complements our chemistry to create a more sustainable future,” said Dr. Matthias Maase, Global Director Sustainability, Care Chemicals BASF. “We are very pleased to have found the right partner in Acies Bio to further develop this innovation at an early stage. With a collaborative and interdisciplinary approach, our research scope of the partnership covers the entire chain from production strain development to large scale manufacturing. This will be of benefit to our customers in Personal Care, Home Care and I&I and Industrial Formulators worldwide.”
Dr. Gregor Kosec, Director of R&D at Acies Bio, said, “Partnering with BASF marks an important milestone, reflecting a significant recognition of Acies Bio’s R&D efforts. By combining our advanced microbial production strains and the OneCarbonBio platform with BASF’s proven process development and supply chain expertise, we are poised to bring our technologies to a global scale. This collaboration demonstrates the transformative potential of Acies Bio’s microbial innovations to drive net-zero production of specialty and industrial chemicals.”
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
